1 High-throughput functional annotation of influenza A virus 1 genome at single-nucleotide resolution 2
暂无分享,去创建一个
S. Nelson | R. Sun | Chung-Yen Lin | N. Wu | Laith Q. Al‐Mawsawi | Hangfei Qi | Ting-Ting Wu | Shu-Hwa Chen | I-Hsuan Lu | Xinmin Li | Jun Feng | Robert G. Chin | Nguyen Nguyen | C. Olson | Luan | Arthur Young | 4. HardingH.
[1] S. Nelson,et al. High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution , 2014, Scientific Reports.
[2] Rong Hai,et al. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins , 2013, Proceedings of the National Academy of Sciences.
[3] 唐亚林. Screen Anti-influenza Lead Compounds That Target the PAC Subunit of H5N1 Viral RNA Polymerase , 2012 .
[4] R. Webby,et al. Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease , 2012, PLoS pathogens.
[5] C. Macken,et al. Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein , 2012, PloS one.
[6] T. Noda,et al. The Highly Conserved Arginine Residues at Positions 76 through 78 of Influenza A Virus Matrix Protein M1 Play an Important Role in Viral Replication by Affecting the Intracellular Localization of M1 , 2011, Journal of Virology.
[7] A. Yang,et al. E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors , 2011, Proceedings of the National Academy of Sciences.
[8] A. Pekosz,et al. Mutations in the Membrane-Proximal Region of the Influenza A Virus M2 Protein Cytoplasmic Tail Have Modest Effects on Virus Replication , 2011, Journal of Virology.
[9] G. Boivin,et al. Influenza drug resistance. , 2011, Seminars in respiratory and critical care medicine.
[10] F. Hayden,et al. Emerging influenza antiviral resistance threats. , 2011, The Journal of infectious diseases.
[11] J. Taubenberger,et al. Influenza: The Once and Future Pandemic , 2010, Public health reports.
[12] Baek Kim,et al. PB2 Residue 271 Plays a Key Role in Enhanced Polymerase Activity of Influenza A Viruses in Mammalian Host Cells , 2010, Journal of Virology.
[13] R. Lamb,et al. Autophagy, apoptosis, and the influenza virus M2 protein. , 2009, Cell host & microbe.
[14] M. Schmidtke,et al. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. , 2009, The Journal of general virology.
[15] Tokiko Watanabe,et al. Mutational Analysis of Conserved Amino Acids in the Influenza A Virus Nucleoprotein , 2009, Journal of Virology.
[16] R. Couch. Seasonal inactivated influenza virus vaccines. , 2008, Vaccine.
[17] E. Obayashi,et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase , 2008, Nature.
[18] S. Kadowaki,et al. PA subunit of RNA polymerase as a promising target for anti-influenza virus agents. , 2008, Antiviral research.
[19] Emmie de Wit,et al. Emerging influenza. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] G. Boivin,et al. Generation and Characterization of Recombinant Influenza A (H1N1) Viruses Harboring Amantadine Resistance Mutations , 2005, Antimicrobial Agents and Chemotherapy.
[21] F. Baudin,et al. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. , 2001, Virology.
[22] Tokiko Watanabe,et al. Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] F. Hayden,et al. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. , 1992, Current topics in microbiology and immunology.